We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$212B
AUM Growth
+$25.4B
Cap. Flow
+$11.1B
Cap. Flow %
5.24%
Top 10 Hldgs %
35.63%
Holding
5,234
New
558
Increased
1,559
Reduced
2,300
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.95%
3 Communication Services 5.87%
4 Consumer Discretionary 5.85%
5 Healthcare 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TOVX icon
5026
Theriva Biologics
TOVX
$9.75M
-2
Closed
TPST icon
5027
Tempest Therapeutics
TPST
$13.7M
-219
Closed -$51K
TRST
5028
Trustco Bank Corp NY
TRST
$969M
-31,770
Closed -$1.17M
TRVI icon
5029
Trevi Therapeutics
TRVI
$2.59B
$0 ﹤0.01%
+100
New +$225
TS icon
5030
Tenaris
TS
$28.9B
-1,938
Closed -$44K
TSN icon
5031
CALL
Tyson Foods
TSN
$21.1B
-2,800
Closed -$208K
TV icon
5032
Televisa
TV
$1.5B
-9,023
Closed -$80K
TXMD icon
5033
TherapeuticsMD
TXMD
$23.5M
-6,134
Closed -$411K
TZOO icon
5034
Travelzoo
TZOO
$73.9M
-211
Closed -$4K
UNB icon
5035
Union Bankshares
UNB
$107M
$0 ﹤0.01%
4
-73
-95% -$2.44K
UNH icon
5036
CALL
UnitedHealth
UNH
$382B
-10,000
Closed -$3.72M
USL icon
5037
United States 12 Month Oil Fund,
USL
$45.1M
$0 ﹤0.01%
16
UTHR icon
5038
PUT
United Therapeutics
UTHR
$25.8B
-33,500
Closed -$5.6M
UVXY icon
5039
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$229M
0
-$5K
UVXY icon
5040
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$229M
-154
Closed -$2.18M
UVXY icon
5041
PUT
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$229M
-1
Closed -$10K
VAW icon
5042
Vanguard Materials ETF
VAW
$2.95B
-95
Closed -$16K
VCIT icon
5043
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
-655,947
Closed -$61M
TONX
5044
TON Strategy Co
TONX
$168M
0
VFH icon
5045
Vanguard Financials ETF
VFH
$13.5B
-8,532
Closed -$721K
VGZ icon
5046
Vista Gold
VGZ
$251M
$0 ﹤0.01%
94
VIXY icon
5047
ProShares VIX Short-Term Futures ETF
VIXY
$204M
-24
Closed -$18K
VNCE icon
5048
Vince Holding Corp
VNCE
$81.2M
-29
Closed
VRNA
5049
DELISTED
Verona Pharma
VRNA
$0 ﹤0.01%
10
-100
-91% -$693
VXX icon
5050
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$156M
-168,598
Closed -$123M

Similar funds

Barclays's Q2 2021 Portfolio in Review

As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.

  • Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
  • Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
  • Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
  • Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
  • Barclays opened 558 new positions and closed 327 in Q2 2021.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $212B.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.